Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.
Samoylovich A, Jennings B, Shannon C, Coward JI, Lourie R, Riordan J, Lai NA, van Driel WJ, Cabraal N, Jagasia N, Chetty N, Naidu S, Perrin LC, Barry SC. Samoylovich A, et al. Among authors: van driel wj. Aust N Z J Obstet Gynaecol. 2023 Oct;63(5):702-708. doi: 10.1111/ajo.13694. Epub 2023 May 31. Aust N Z J Obstet Gynaecol. 2023. PMID: 37259677
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, Zivanovic O, Mosgaard BJ, Fagotti A, Colombo PE, Sonke G, Driel WJV; OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group. Koole S, et al. Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23. Int J Gynecol Cancer. 2020. PMID: 32205449 Free PMC article.
Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.
van Stein RM, Sikorska K, van der Aa MA, Sonke GS, van Driel WJ; Dutch OVHIPEC-1 trial group. van Stein RM, et al. Among authors: van der aa ma, van driel wj. Int J Gynaecol Obstet. 2023 May;161(2):640-648. doi: 10.1002/ijgo.14618. Epub 2022 Dec 26. Int J Gynaecol Obstet. 2023. PMID: 36495280
Exploring international differences in ovarian cancer care: a survey report on global patterns of care, current practices, and barriers.
Algera MD, Morton R, Sundar SS, Farrell R, van Driel WJ, Brennan D, Rijken MJ, Sfeir S, Allen L, Eiken M, Coleman RL; collaborators of the Global Equality in Ovarian Cancer Care project group. Algera MD, et al. Among authors: van driel wj. Int J Gynecol Cancer. 2023 Oct 2;33(10):1612-1620. doi: 10.1136/ijgc-2023-004563. Int J Gynecol Cancer. 2023. PMID: 37591611 Free PMC article.
Clinical outcomes of pelvic exenteration for gynecologic malignancies.
Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, van Driel WJ, van Lonkhuijzen LRCW, Mom CH, Zaal A. Moolenaar LR, et al. Among authors: van lonkhuijzen lrcw, van poelgeest mie, van rangelrooij le, van beurden m, van driel wj. Gynecol Oncol. 2023 Apr;171:114-120. doi: 10.1016/j.ygyno.2023.02.010. Epub 2023 Mar 2. Gynecol Oncol. 2023. PMID: 36870097 Free article.
Psychological impact of referral to an oncology hospital on patients with an ovarian mass.
Lof P, Engelhardt EG, van Gent MDJM, Mom CH, Rosier-van Dunné FMF, van Baal WM, Verhoeve HR, Hermsen BBJ, Verbruggen MB, Hemelaar M, van de Swaluw JMG, Knipscheer HC, Huirne JAF, Westenberg SM, van Driel WJ, Bleiker EMA, Amant F, Lok CAR. Lof P, et al. Among authors: van baal wm, van gent mdjm, van de swaluw jmg, van driel wj. Int J Gynecol Cancer. 2022 Dec 13:ijgc-2022-003753. doi: 10.1136/ijgc-2022-003753. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 36600495
92 results